HEADER TRANSFERASE/CELL CYCLE 02-OCT-12 4BCM TITLE STRUCTURE OF CDK2 IN COMPLEX WITH CYCLIN A AND A 2-AMINO-4-HETEROARYL- TITLE 2 PYRIMIDINE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYCLIN-DEPENDENT KINASE 2; COMPND 3 CHAIN: A, C; COMPND 4 SYNONYM: CELL DIVISION PROTEIN KINASE 2, P33 PROTEIN KINASE; COMPND 5 EC: 2.7.11.22; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: CYCLIN-A2; COMPND 9 CHAIN: B; COMPND 10 FRAGMENT: RESIDUES 171-432; COMPND 11 SYNONYM: CYCLIN-A; COMPND 12 ENGINEERED: YES; COMPND 13 MOL_ID: 3; COMPND 14 MOLECULE: CYCLIN-A2; COMPND 15 CHAIN: D; COMPND 16 FRAGMENT: RESIDUES 171-432; COMPND 17 SYNONYM: CYCLIN-A; COMPND 18 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 MOL_ID: 2; SOURCE 8 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 9 ORGANISM_COMMON: HUMAN; SOURCE 10 ORGANISM_TAXID: 9606; SOURCE 11 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 12 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 13 MOL_ID: 3; SOURCE 14 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 15 ORGANISM_COMMON: HUMAN; SOURCE 16 ORGANISM_TAXID: 9606; SOURCE 17 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 18 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS TRANSFERASE-CELL CYCLE COMPLEX, CDK-CYCLIN COMPLEX, STRUCTURE-BASED KEYWDS 2 DRUG DESIGN EXPDTA X-RAY DIFFRACTION AUTHOR A.J.HOLE,S.BAUMLI,S.WANG,J.A.ENDICOTT,M.E.M.NOBLE REVDAT 2 23-OCT-24 4BCM 1 REMARK LINK REVDAT 1 06-MAR-13 4BCM 0 JRNL AUTH A.J.HOLE,S.BAUMLI,H.SHAO,S.SHI,C.PEPPER,P.M.FISCHER,S.WANG, JRNL AUTH 2 J.A.ENDICOTT,M.E.M.NOBLE JRNL TITL COMPARATIVE STRUCTURAL AND FUNCTIONAL STUDIES OF 4-(THIAZOL- JRNL TITL 2 5-YL)-2-(PHENYLAMINO)PYRIMIDINE-5-CARBONITRILE CDK9 JRNL TITL 3 INHIBITORS SUGGEST THE BASIS FOR ISOTYPE SELECTIVITY. JRNL REF J.MED.CHEM. V. 56 660 2013 JRNL REFN ISSN 0022-2623 JRNL PMID 23252711 JRNL DOI 10.1021/JM301495V REMARK 2 REMARK 2 RESOLUTION. 2.45 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.45 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 52.46 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 3 NUMBER OF REFLECTIONS : 55144 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.198 REMARK 3 R VALUE (WORKING SET) : 0.196 REMARK 3 FREE R VALUE : 0.258 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.600 REMARK 3 FREE R VALUE TEST SET COUNT : 1999 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 52.4738 - 5.9023 0.96 3933 147 0.1954 0.2493 REMARK 3 2 5.9023 - 4.6858 0.98 3823 144 0.1706 0.2276 REMARK 3 3 4.6858 - 4.0937 0.98 3808 143 0.1458 0.1945 REMARK 3 4 4.0937 - 3.7196 0.99 3817 144 0.1554 0.2230 REMARK 3 5 3.7196 - 3.4530 1.00 3821 144 0.1760 0.2209 REMARK 3 6 3.4530 - 3.2495 1.00 3806 143 0.1846 0.2645 REMARK 3 7 3.2495 - 3.0867 0.99 3754 141 0.1995 0.2577 REMARK 3 8 3.0867 - 2.9524 0.99 3813 144 0.2200 0.3105 REMARK 3 9 2.9524 - 2.8387 0.99 3759 141 0.2290 0.3110 REMARK 3 10 2.8387 - 2.7408 0.99 3770 142 0.2409 0.3194 REMARK 3 11 2.7408 - 2.6551 0.99 3745 141 0.2534 0.3138 REMARK 3 12 2.6551 - 2.5792 0.99 3782 142 0.2825 0.3578 REMARK 3 13 2.5792 - 2.5113 0.99 3772 143 0.3093 0.3846 REMARK 3 14 2.5113 - 2.4500 1.00 3742 140 0.3207 0.3714 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.20 REMARK 3 SHRINKAGE RADIUS : 0.95 REMARK 3 K_SOL : 0.38 REMARK 3 B_SOL : 49.74 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.850 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.480 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 41.12 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -5.00550 REMARK 3 B22 (A**2) : 2.83610 REMARK 3 B33 (A**2) : 2.16930 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 9049 REMARK 3 ANGLE : 0.964 12285 REMARK 3 CHIRALITY : 0.063 1378 REMARK 3 PLANARITY : 0.004 1532 REMARK 3 DIHEDRAL : 15.134 3396 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 6 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN A AND (RESSEQ 1:85) REMARK 3 ORIGIN FOR THE GROUP (A): 10.6777 14.3532 24.3445 REMARK 3 T TENSOR REMARK 3 T11: 0.2078 T22: 0.2961 REMARK 3 T33: 0.2063 T12: -0.0350 REMARK 3 T13: 0.0115 T23: 0.0100 REMARK 3 L TENSOR REMARK 3 L11: 0.3242 L22: 1.8671 REMARK 3 L33: 1.8461 L12: 0.1744 REMARK 3 L13: 0.0594 L23: 0.9211 REMARK 3 S TENSOR REMARK 3 S11: 0.0841 S12: -0.2439 S13: -0.1462 REMARK 3 S21: 0.1444 S22: -0.3148 S23: 0.1673 REMARK 3 S31: 0.1669 S32: -0.3376 S33: 0.1353 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN A AND (RESSEQ 86:298) REMARK 3 ORIGIN FOR THE GROUP (A): 4.8776 31.4373 3.9811 REMARK 3 T TENSOR REMARK 3 T11: 0.0793 T22: 0.1819 REMARK 3 T33: 0.1939 T12: 0.0039 REMARK 3 T13: 0.0257 T23: 0.0136 REMARK 3 L TENSOR REMARK 3 L11: 1.5250 L22: 0.5945 REMARK 3 L33: 0.5703 L12: -0.2515 REMARK 3 L13: 0.5859 L23: -0.3675 REMARK 3 S TENSOR REMARK 3 S11: 0.0460 S12: 0.0089 S13: 0.1384 REMARK 3 S21: -0.0327 S22: -0.0318 S23: 0.0156 REMARK 3 S31: -0.0501 S32: -0.0562 S33: 0.0025 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: CHAIN B REMARK 3 ORIGIN FOR THE GROUP (A): 21.6305 -0.1252 -2.9672 REMARK 3 T TENSOR REMARK 3 T11: 0.1503 T22: 0.1066 REMARK 3 T33: 0.1433 T12: 0.0070 REMARK 3 T13: -0.0071 T23: -0.0159 REMARK 3 L TENSOR REMARK 3 L11: 1.0054 L22: 1.0011 REMARK 3 L33: 1.3369 L12: 0.3431 REMARK 3 L13: -0.1706 L23: -0.0880 REMARK 3 S TENSOR REMARK 3 S11: -0.0411 S12: 0.0876 S13: -0.0513 REMARK 3 S21: -0.0335 S22: 0.0375 S23: -0.0201 REMARK 3 S31: 0.2300 S32: -0.0018 S33: 0.0094 REMARK 3 TLS GROUP : 4 REMARK 3 SELECTION: CHAIN C AND (RESSEQ 1:85) REMARK 3 ORIGIN FOR THE GROUP (A): 28.3980 -8.1867 31.6681 REMARK 3 T TENSOR REMARK 3 T11: 0.2756 T22: 0.3965 REMARK 3 T33: 0.1638 T12: 0.0643 REMARK 3 T13: -0.0189 T23: 0.1126 REMARK 3 L TENSOR REMARK 3 L11: 0.6208 L22: 0.9854 REMARK 3 L33: 0.8112 L12: 0.1777 REMARK 3 L13: 0.1885 L23: 0.6388 REMARK 3 S TENSOR REMARK 3 S11: 0.0555 S12: -0.3283 S13: -0.1301 REMARK 3 S21: 0.1623 S22: -0.1152 S23: 0.0146 REMARK 3 S31: 0.1755 S32: 0.1321 S33: 0.0399 REMARK 3 TLS GROUP : 5 REMARK 3 SELECTION: CHAIN C AND (RESSEQ 86:298) REMARK 3 ORIGIN FOR THE GROUP (A): 55.1021 -14.5707 34.1527 REMARK 3 T TENSOR REMARK 3 T11: 0.2981 T22: 0.9365 REMARK 3 T33: 0.3792 T12: 0.2744 REMARK 3 T13: 0.0469 T23: 0.3038 REMARK 3 L TENSOR REMARK 3 L11: 0.3191 L22: 1.0351 REMARK 3 L33: 0.2982 L12: -0.2873 REMARK 3 L13: -0.1533 L23: -0.2797 REMARK 3 S TENSOR REMARK 3 S11: -0.0198 S12: -0.3514 S13: -0.0950 REMARK 3 S21: 0.0340 S22: -0.1654 S23: -0.4226 REMARK 3 S31: 0.2033 S32: 0.6222 S33: 0.1510 REMARK 3 TLS GROUP : 6 REMARK 3 SELECTION: CHAIN D REMARK 3 ORIGIN FOR THE GROUP (A): 43.0768 19.6267 34.7201 REMARK 3 T TENSOR REMARK 3 T11: 0.3435 T22: 0.6892 REMARK 3 T33: 0.2521 T12: -0.4054 REMARK 3 T13: 0.0258 T23: 0.0096 REMARK 3 L TENSOR REMARK 3 L11: 0.8113 L22: 0.8617 REMARK 3 L33: 0.5118 L12: -0.0057 REMARK 3 L13: -0.1387 L23: -0.0734 REMARK 3 S TENSOR REMARK 3 S11: 0.0476 S12: -0.1908 S13: 0.2340 REMARK 3 S21: -0.0790 S22: -0.0639 S23: -0.3498 REMARK 3 S31: -0.3129 S32: 0.6883 S33: -0.0249 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4BCM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 02-OCT-12. REMARK 100 THE DEPOSITION ID IS D_1290054251. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I02 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 55186 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.390 REMARK 200 RESOLUTION RANGE LOW (A) : 59.540 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : 3.470 REMARK 200 R MERGE (I) : 0.11000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 5.2500 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.45 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.58 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.7 REMARK 200 DATA REDUNDANCY IN SHELL : 3.52 REMARK 200 R MERGE FOR SHELL (I) : 0.53000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.420 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.00 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: COCRYSTALS WERE GROWN IN 1-1.25M REMARK 280 AMMONIUM SULFATE, 0.5-0.9M KCL, IN THE PRESENCE OF 100MM HEPES, REMARK 280 PH 7.0, 5MM DTT AND COMPOUND REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 37.03500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 74.31500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 67.70500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 74.31500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 37.03500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 67.70500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3330 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 23200 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -14.2 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3520 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 22570 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -14.4 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A 38 REMARK 465 THR A 39 REMARK 465 GLU A 40 REMARK 465 ARG A 297 REMARK 465 LEU A 298 REMARK 465 SER B 171 REMARK 465 VAL B 172 REMARK 465 ASN B 173 REMARK 465 GLU B 174 REMARK 465 VAL B 175 REMARK 465 PRO C -2 REMARK 465 GLY C -1 REMARK 465 HIS C 295 REMARK 465 LEU C 296 REMARK 465 ARG C 297 REMARK 465 LEU C 298 REMARK 465 SER D 171 REMARK 465 VAL D 172 REMARK 465 ASN D 173 REMARK 465 GLU D 174 REMARK 465 VAL D 175 REMARK 465 GLN D 322 REMARK 465 GLN D 323 REMARK 465 PRO D 324 REMARK 465 ALA D 325 REMARK 465 ASN D 326 REMARK 465 CYS D 327 REMARK 465 LYS D 328 REMARK 465 VAL D 329 REMARK 465 GLU D 330 REMARK 465 LEU D 364 REMARK 465 TYR D 365 REMARK 465 THR D 366 REMARK 465 VAL D 367 REMARK 465 THR D 368 REMARK 465 GLY D 369 REMARK 465 GLN D 370 REMARK 465 SER D 371 REMARK 465 THR D 429 REMARK 465 LEU D 430 REMARK 465 ASN D 431 REMARK 465 LEU D 432 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE1 GLN B 317 O HOH B 2016 2.06 REMARK 500 O ARG C 157 O HOH C 2024 2.11 REMARK 500 O HOH A 2036 O HOH A 2116 2.11 REMARK 500 O PRO C 204 O HOH C 2034 2.12 REMARK 500 O GLN B 203 O HOH B 2025 2.12 REMARK 500 OE2 GLU A 51 O HOH A 2016 2.16 REMARK 500 O GLN D 203 O HOH D 2002 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 8 160.91 177.32 REMARK 500 THR A 72 -160.04 -123.45 REMARK 500 SER A 94 31.89 -82.85 REMARK 500 ASP A 127 40.91 -159.40 REMARK 500 ASP A 145 79.02 58.72 REMARK 500 VAL A 164 129.96 79.09 REMARK 500 SER A 181 -155.91 -145.56 REMARK 500 TRP B 372 108.21 -47.28 REMARK 500 ASN B 431 82.15 64.48 REMARK 500 THR C 41 -85.37 -127.00 REMARK 500 LEU C 96 -70.28 -81.40 REMARK 500 ASP C 127 38.17 -157.59 REMARK 500 LYS C 129 153.93 175.20 REMARK 500 ASP C 145 79.88 58.31 REMARK 500 VAL C 164 132.37 70.08 REMARK 500 LEU C 166 -73.96 -11.16 REMARK 500 SER C 181 -156.64 -152.24 REMARK 500 PRO C 204 63.72 -66.04 REMARK 500 THR C 218 -37.78 -130.12 REMARK 500 ASP C 256 -172.92 -59.91 REMARK 500 THR C 290 -165.77 -127.46 REMARK 500 PRO D 373 156.46 -47.87 REMARK 500 LEU D 387 32.73 -94.04 REMARK 500 TYR D 413 30.99 -90.24 REMARK 500 PRO D 427 39.50 -66.47 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SGM D 1429 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SGM B 1433 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE T7Z C 1295 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE T7Z A 1297 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4BCF RELATED DB: PDB REMARK 900 STRUCTURE OF CDK9 IN COMPLEX WITH CYCLIN T AND A 2 -AMINO-4- REMARK 900 HETEROARYL-PYRIMIDINE INHIBITOR REMARK 900 RELATED ID: 4BCG RELATED DB: PDB REMARK 900 STRUCTURE OF CDK9 IN COMPLEX WITH CYCLIN T AND A 2 -AMINO-4- REMARK 900 HETEROARYL-PYRIMIDINE INHIBITOR REMARK 900 RELATED ID: 4BCH RELATED DB: PDB REMARK 900 STRUCTURE OF CDK9 IN COMPLEX WITH CYCLIN T AND A 2 -AMINO-4- REMARK 900 HETEROARYL-PYRIMIDINE INHIBITOR REMARK 900 RELATED ID: 4BCI RELATED DB: PDB REMARK 900 STRUCTURE OF CDK9 IN COMPLEX WITH CYCLIN T AND A 2 -AMINO-4- REMARK 900 HETEROARYL-PYRIMIDINE INHIBITOR REMARK 900 RELATED ID: 4BCJ RELATED DB: PDB REMARK 900 STRUCTURE OF CDK9 IN COMPLEX WITH CYCLIN T AND A 2 -AMINO-4- REMARK 900 HETEROARYL-PYRIMIDINE INHIBITOR REMARK 900 RELATED ID: 4BCK RELATED DB: PDB REMARK 900 STRUCTURE OF CDK2 IN COMPLEX WITH CYCLIN A AND A 2 -AMINO-4- REMARK 900 HETEROARYL-PYRIMIDINE INHIBITOR REMARK 900 RELATED ID: 4BCN RELATED DB: PDB REMARK 900 STRUCTURE OF CDK2 IN COMPLEX WITH CYCLIN A AND A 2 -AMINO-4- REMARK 900 HETEROARYL-PYRIMIDINE INHIBITOR REMARK 900 RELATED ID: 4BCO RELATED DB: PDB REMARK 900 STRUCTURE OF CDK2 IN COMPLEX WITH CYCLIN A AND A 2 -AMINO-4- REMARK 900 HETEROARYL-PYRIMIDINE INHIBITOR REMARK 900 RELATED ID: 4BCP RELATED DB: PDB REMARK 900 STRUCTURE OF CDK2 IN COMPLEX WITH CYCLIN A AND A 2 -AMINO-4- REMARK 900 HETEROARYL-PYRIMIDINE INHIBITOR REMARK 900 RELATED ID: 4BCQ RELATED DB: PDB REMARK 900 STRUCTURE OF CDK2 IN COMPLEX WITH CYCLIN A AND A 2 -AMINO-4- REMARK 900 HETEROARYL-PYRIMIDINE INHIBITOR DBREF 4BCM A 1 298 UNP P24941 CDK2_HUMAN 1 298 DBREF 4BCM B 171 432 UNP P20248 CCNA2_HUMAN 171 432 DBREF 4BCM C 1 298 UNP P24941 CDK2_HUMAN 1 298 DBREF 4BCM D 171 432 UNP P20248 CCNA2_HUMAN 171 432 SEQADV 4BCM PRO A -2 UNP P24941 EXPRESSION TAG SEQADV 4BCM GLY A -1 UNP P24941 EXPRESSION TAG SEQADV 4BCM SER A 0 UNP P24941 EXPRESSION TAG SEQADV 4BCM PRO C -2 UNP P24941 EXPRESSION TAG SEQADV 4BCM GLY C -1 UNP P24941 EXPRESSION TAG SEQADV 4BCM SER C 0 UNP P24941 EXPRESSION TAG SEQADV 4BCM LEU D 331 UNP P20248 SER 331 CONFLICT SEQRES 1 A 301 PRO GLY SER MET GLU ASN PHE GLN LYS VAL GLU LYS ILE SEQRES 2 A 301 GLY GLU GLY THR TYR GLY VAL VAL TYR LYS ALA ARG ASN SEQRES 3 A 301 LYS LEU THR GLY GLU VAL VAL ALA LEU LYS LYS ILE ARG SEQRES 4 A 301 LEU ASP THR GLU THR GLU GLY VAL PRO SER THR ALA ILE SEQRES 5 A 301 ARG GLU ILE SER LEU LEU LYS GLU LEU ASN HIS PRO ASN SEQRES 6 A 301 ILE VAL LYS LEU LEU ASP VAL ILE HIS THR GLU ASN LYS SEQRES 7 A 301 LEU TYR LEU VAL PHE GLU PHE LEU HIS GLN ASP LEU LYS SEQRES 8 A 301 LYS PHE MET ASP ALA SER ALA LEU THR GLY ILE PRO LEU SEQRES 9 A 301 PRO LEU ILE LYS SER TYR LEU PHE GLN LEU LEU GLN GLY SEQRES 10 A 301 LEU ALA PHE CYS HIS SER HIS ARG VAL LEU HIS ARG ASP SEQRES 11 A 301 LEU LYS PRO GLN ASN LEU LEU ILE ASN THR GLU GLY ALA SEQRES 12 A 301 ILE LYS LEU ALA ASP PHE GLY LEU ALA ARG ALA PHE GLY SEQRES 13 A 301 VAL PRO VAL ARG THR TYR TPO HIS GLU VAL VAL THR LEU SEQRES 14 A 301 TRP TYR ARG ALA PRO GLU ILE LEU LEU GLY CYS LYS TYR SEQRES 15 A 301 TYR SER THR ALA VAL ASP ILE TRP SER LEU GLY CYS ILE SEQRES 16 A 301 PHE ALA GLU MET VAL THR ARG ARG ALA LEU PHE PRO GLY SEQRES 17 A 301 ASP SER GLU ILE ASP GLN LEU PHE ARG ILE PHE ARG THR SEQRES 18 A 301 LEU GLY THR PRO ASP GLU VAL VAL TRP PRO GLY VAL THR SEQRES 19 A 301 SER MET PRO ASP TYR LYS PRO SER PHE PRO LYS TRP ALA SEQRES 20 A 301 ARG GLN ASP PHE SER LYS VAL VAL PRO PRO LEU ASP GLU SEQRES 21 A 301 ASP GLY ARG SER LEU LEU SER GLN MET LEU HIS TYR ASP SEQRES 22 A 301 PRO ASN LYS ARG ILE SER ALA LYS ALA ALA LEU ALA HIS SEQRES 23 A 301 PRO PHE PHE GLN ASP VAL THR LYS PRO VAL PRO HIS LEU SEQRES 24 A 301 ARG LEU SEQRES 1 B 262 SER VAL ASN GLU VAL PRO ASP TYR HIS GLU ASP ILE HIS SEQRES 2 B 262 THR TYR LEU ARG GLU MET GLU VAL LYS CYS LYS PRO LYS SEQRES 3 B 262 VAL GLY TYR MET LYS LYS GLN PRO ASP ILE THR ASN SER SEQRES 4 B 262 MET ARG ALA ILE LEU VAL ASP TRP LEU VAL GLU VAL GLY SEQRES 5 B 262 GLU GLU TYR LYS LEU GLN ASN GLU THR LEU HIS LEU ALA SEQRES 6 B 262 VAL ASN TYR ILE ASP ARG PHE LEU SER SER MET SER VAL SEQRES 7 B 262 LEU ARG GLY LYS LEU GLN LEU VAL GLY THR ALA ALA MET SEQRES 8 B 262 LEU LEU ALA SER LYS PHE GLU GLU ILE TYR PRO PRO GLU SEQRES 9 B 262 VAL ALA GLU PHE VAL TYR ILE THR ASP ASP THR TYR THR SEQRES 10 B 262 LYS LYS GLN VAL LEU ARG MET GLU HIS LEU VAL LEU LYS SEQRES 11 B 262 VAL LEU THR PHE ASP LEU ALA ALA PRO THR VAL ASN GLN SEQRES 12 B 262 PHE LEU THR GLN TYR PHE LEU HIS GLN GLN PRO ALA ASN SEQRES 13 B 262 CYS LYS VAL GLU SER LEU ALA MET PHE LEU GLY GLU LEU SEQRES 14 B 262 SER LEU ILE ASP ALA ASP PRO TYR LEU LYS TYR LEU PRO SEQRES 15 B 262 SER VAL ILE ALA GLY ALA ALA PHE HIS LEU ALA LEU TYR SEQRES 16 B 262 THR VAL THR GLY GLN SER TRP PRO GLU SER LEU ILE ARG SEQRES 17 B 262 LYS THR GLY TYR THR LEU GLU SER LEU LYS PRO CYS LEU SEQRES 18 B 262 MET ASP LEU HIS GLN THR TYR LEU LYS ALA PRO GLN HIS SEQRES 19 B 262 ALA GLN GLN SER ILE ARG GLU LYS TYR LYS ASN SER LYS SEQRES 20 B 262 TYR HIS GLY VAL SER LEU LEU ASN PRO PRO GLU THR LEU SEQRES 21 B 262 ASN LEU SEQRES 1 C 301 PRO GLY SER MET GLU ASN PHE GLN LYS VAL GLU LYS ILE SEQRES 2 C 301 GLY GLU GLY THR TYR GLY VAL VAL TYR LYS ALA ARG ASN SEQRES 3 C 301 LYS LEU THR GLY GLU VAL VAL ALA LEU LYS LYS ILE ARG SEQRES 4 C 301 LEU ASP THR GLU THR GLU GLY VAL PRO SER THR ALA ILE SEQRES 5 C 301 ARG GLU ILE SER LEU LEU LYS GLU LEU ASN HIS PRO ASN SEQRES 6 C 301 ILE VAL LYS LEU LEU ASP VAL ILE HIS THR GLU ASN LYS SEQRES 7 C 301 LEU TYR LEU VAL PHE GLU PHE LEU HIS GLN ASP LEU LYS SEQRES 8 C 301 LYS PHE MET ASP ALA SER ALA LEU THR GLY ILE PRO LEU SEQRES 9 C 301 PRO LEU ILE LYS SER TYR LEU PHE GLN LEU LEU GLN GLY SEQRES 10 C 301 LEU ALA PHE CYS HIS SER HIS ARG VAL LEU HIS ARG ASP SEQRES 11 C 301 LEU LYS PRO GLN ASN LEU LEU ILE ASN THR GLU GLY ALA SEQRES 12 C 301 ILE LYS LEU ALA ASP PHE GLY LEU ALA ARG ALA PHE GLY SEQRES 13 C 301 VAL PRO VAL ARG THR TYR TPO HIS GLU VAL VAL THR LEU SEQRES 14 C 301 TRP TYR ARG ALA PRO GLU ILE LEU LEU GLY CYS LYS TYR SEQRES 15 C 301 TYR SER THR ALA VAL ASP ILE TRP SER LEU GLY CYS ILE SEQRES 16 C 301 PHE ALA GLU MET VAL THR ARG ARG ALA LEU PHE PRO GLY SEQRES 17 C 301 ASP SER GLU ILE ASP GLN LEU PHE ARG ILE PHE ARG THR SEQRES 18 C 301 LEU GLY THR PRO ASP GLU VAL VAL TRP PRO GLY VAL THR SEQRES 19 C 301 SER MET PRO ASP TYR LYS PRO SER PHE PRO LYS TRP ALA SEQRES 20 C 301 ARG GLN ASP PHE SER LYS VAL VAL PRO PRO LEU ASP GLU SEQRES 21 C 301 ASP GLY ARG SER LEU LEU SER GLN MET LEU HIS TYR ASP SEQRES 22 C 301 PRO ASN LYS ARG ILE SER ALA LYS ALA ALA LEU ALA HIS SEQRES 23 C 301 PRO PHE PHE GLN ASP VAL THR LYS PRO VAL PRO HIS LEU SEQRES 24 C 301 ARG LEU SEQRES 1 D 262 SER VAL ASN GLU VAL PRO ASP TYR HIS GLU ASP ILE HIS SEQRES 2 D 262 THR TYR LEU ARG GLU MET GLU VAL LYS CYS LYS PRO LYS SEQRES 3 D 262 VAL GLY TYR MET LYS LYS GLN PRO ASP ILE THR ASN SER SEQRES 4 D 262 MET ARG ALA ILE LEU VAL ASP TRP LEU VAL GLU VAL GLY SEQRES 5 D 262 GLU GLU TYR LYS LEU GLN ASN GLU THR LEU HIS LEU ALA SEQRES 6 D 262 VAL ASN TYR ILE ASP ARG PHE LEU SER SER MET SER VAL SEQRES 7 D 262 LEU ARG GLY LYS LEU GLN LEU VAL GLY THR ALA ALA MET SEQRES 8 D 262 LEU LEU ALA SER LYS PHE GLU GLU ILE TYR PRO PRO GLU SEQRES 9 D 262 VAL ALA GLU PHE VAL TYR ILE THR ASP ASP THR TYR THR SEQRES 10 D 262 LYS LYS GLN VAL LEU ARG MET GLU HIS LEU VAL LEU LYS SEQRES 11 D 262 VAL LEU THR PHE ASP LEU ALA ALA PRO THR VAL ASN GLN SEQRES 12 D 262 PHE LEU THR GLN TYR PHE LEU HIS GLN GLN PRO ALA ASN SEQRES 13 D 262 CYS LYS VAL GLU LEU LEU ALA MET PHE LEU GLY GLU LEU SEQRES 14 D 262 SER LEU ILE ASP ALA ASP PRO TYR LEU LYS TYR LEU PRO SEQRES 15 D 262 SER VAL ILE ALA GLY ALA ALA PHE HIS LEU ALA LEU TYR SEQRES 16 D 262 THR VAL THR GLY GLN SER TRP PRO GLU SER LEU ILE ARG SEQRES 17 D 262 LYS THR GLY TYR THR LEU GLU SER LEU LYS PRO CYS LEU SEQRES 18 D 262 MET ASP LEU HIS GLN THR TYR LEU LYS ALA PRO GLN HIS SEQRES 19 D 262 ALA GLN GLN SER ILE ARG GLU LYS TYR LYS ASN SER LYS SEQRES 20 D 262 TYR HIS GLY VAL SER LEU LEU ASN PRO PRO GLU THR LEU SEQRES 21 D 262 ASN LEU MODRES 4BCM TPO A 160 THR PHOSPHOTHREONINE MODRES 4BCM TPO C 160 THR PHOSPHOTHREONINE HET TPO A 160 11 HET TPO C 160 11 HET T7Z A1297 33 HET SGM B1433 6 HET T7Z C1295 33 HET SGM D1429 6 HETNAM TPO PHOSPHOTHREONINE HETNAM T7Z 4-(4-METHYL-2-METHYLIMINO-3H-1,3-THIAZOL-5-YL)-2-[(4- HETNAM 2 T7Z METHYL-3-MORPHOLIN-4-YLSULFONYL-PHENYL) HETNAM 3 T7Z AMINO]PYRIMIDINE-5-CARBONITRILE HETNAM SGM MONOTHIOGLYCEROL HETSYN TPO PHOSPHONOTHREONINE FORMUL 1 TPO 2(C4 H10 N O6 P) FORMUL 5 T7Z 2(C21 H23 N7 O3 S2) FORMUL 6 SGM 2(C3 H8 O2 S) FORMUL 9 HOH *287(H2 O) HELIX 1 1 SER A 0 GLU A 2 5 3 HELIX 2 2 PRO A 45 LEU A 58 1 14 HELIX 3 3 LEU A 87 SER A 94 1 8 HELIX 4 4 PRO A 100 HIS A 121 1 22 HELIX 5 5 LYS A 129 GLN A 131 5 3 HELIX 6 6 THR A 165 ARG A 169 5 5 HELIX 7 7 ALA A 170 LEU A 175 1 6 HELIX 8 8 THR A 182 ARG A 199 1 18 HELIX 9 9 SER A 207 GLY A 220 1 14 HELIX 10 10 GLY A 229 MET A 233 5 5 HELIX 11 11 ASP A 247 VAL A 252 1 6 HELIX 12 12 ASP A 256 LEU A 267 1 12 HELIX 13 13 SER A 276 LEU A 281 1 6 HELIX 14 14 ALA A 282 GLN A 287 5 6 HELIX 15 15 TYR B 178 CYS B 193 1 16 HELIX 16 16 THR B 207 TYR B 225 1 19 HELIX 17 17 GLN B 228 SER B 244 1 17 HELIX 18 18 LEU B 249 GLU B 269 1 21 HELIX 19 19 GLU B 274 THR B 282 1 9 HELIX 20 20 THR B 287 LEU B 302 1 16 HELIX 21 21 THR B 310 LEU B 320 1 11 HELIX 22 22 ASN B 326 ASP B 343 1 18 HELIX 23 23 ASP B 343 LEU B 348 1 6 HELIX 24 24 LEU B 351 GLY B 369 1 19 HELIX 25 25 PRO B 373 GLY B 381 1 9 HELIX 26 26 THR B 383 ALA B 401 1 19 HELIX 27 27 PRO B 402 HIS B 404 5 3 HELIX 28 28 GLN B 407 TYR B 413 1 7 HELIX 29 29 LYS B 414 HIS B 419 5 6 HELIX 30 30 GLY B 420 LEU B 424 5 5 HELIX 31 31 PRO C 45 LYS C 56 1 12 HELIX 32 32 LEU C 87 SER C 94 1 8 HELIX 33 33 PRO C 100 SER C 120 1 21 HELIX 34 34 LYS C 129 GLN C 131 5 3 HELIX 35 35 ASP C 145 ALA C 149 5 5 HELIX 36 36 THR C 165 ARG C 169 5 5 HELIX 37 37 ALA C 170 LEU C 175 1 6 HELIX 38 38 THR C 182 ARG C 199 1 18 HELIX 39 39 SER C 207 GLY C 220 1 14 HELIX 40 40 ASP C 247 VAL C 252 1 6 HELIX 41 41 ASP C 256 LEU C 267 1 12 HELIX 42 42 SER C 276 HIS C 283 1 8 HELIX 43 43 PRO C 284 GLN C 287 5 4 HELIX 44 44 TYR D 178 CYS D 193 1 16 HELIX 45 45 THR D 207 LYS D 226 1 20 HELIX 46 46 GLN D 228 MET D 246 1 19 HELIX 47 47 LEU D 249 GLY D 251 5 3 HELIX 48 48 LYS D 252 GLU D 269 1 18 HELIX 49 49 GLU D 274 THR D 282 1 9 HELIX 50 50 THR D 287 LEU D 302 1 16 HELIX 51 51 THR D 310 PHE D 319 1 10 HELIX 52 52 LEU D 331 ASP D 343 1 13 HELIX 53 53 ASP D 343 LEU D 348 1 6 HELIX 54 54 LEU D 351 ALA D 363 1 13 HELIX 55 55 PRO D 373 GLY D 381 1 9 HELIX 56 56 LEU D 387 LYS D 400 1 14 HELIX 57 57 ALA D 401 HIS D 404 5 4 HELIX 58 58 GLN D 407 TYR D 413 1 7 HELIX 59 59 LYS D 414 HIS D 419 5 6 HELIX 60 60 GLY D 420 LEU D 424 5 5 SHEET 1 AA 5 PHE A 4 GLU A 12 0 SHEET 2 AA 5 GLY A 16 ASN A 23 -1 O VAL A 18 N ILE A 10 SHEET 3 AA 5 VAL A 29 ARG A 36 -1 O VAL A 30 N ALA A 21 SHEET 4 AA 5 LYS A 75 GLU A 81 -1 O LEU A 76 N ILE A 35 SHEET 5 AA 5 LEU A 66 HIS A 71 -1 N LEU A 67 O VAL A 79 SHEET 1 AB 3 GLN A 85 ASP A 86 0 SHEET 2 AB 3 LEU A 133 ILE A 135 -1 O ILE A 135 N GLN A 85 SHEET 3 AB 3 ILE A 141 LEU A 143 -1 O LYS A 142 N LEU A 134 SHEET 1 AC 2 VAL A 123 LEU A 124 0 SHEET 2 AC 2 ARG A 150 ALA A 151 -1 O ARG A 150 N LEU A 124 SHEET 1 CA 5 PHE C 4 GLU C 12 0 SHEET 2 CA 5 GLY C 16 ASN C 23 -1 O VAL C 18 N ILE C 10 SHEET 3 CA 5 VAL C 29 ARG C 36 -1 O VAL C 30 N ALA C 21 SHEET 4 CA 5 LYS C 75 GLU C 81 -1 O LEU C 76 N ILE C 35 SHEET 5 CA 5 LEU C 66 ILE C 70 -1 N LEU C 67 O VAL C 79 SHEET 1 CB 3 GLN C 85 ASP C 86 0 SHEET 2 CB 3 LEU C 133 ILE C 135 -1 O ILE C 135 N GLN C 85 SHEET 3 CB 3 ILE C 141 LEU C 143 -1 O LYS C 142 N LEU C 134 SHEET 1 CC 2 VAL C 123 LEU C 124 0 SHEET 2 CC 2 ARG C 150 ALA C 151 -1 O ARG C 150 N LEU C 124 LINK C TYR A 159 N TPO A 160 1555 1555 1.33 LINK C TPO A 160 N HIS A 161 1555 1555 1.33 LINK C TYR C 159 N TPO C 160 1555 1555 1.33 LINK C TPO C 160 N HIS C 161 1555 1555 1.33 CISPEP 1 VAL A 154 PRO A 155 0 -11.17 CISPEP 2 GLN B 323 PRO B 324 0 -6.50 CISPEP 3 ASP B 345 PRO B 346 0 11.04 CISPEP 4 VAL C 154 PRO C 155 0 -0.44 CISPEP 5 ASP D 345 PRO D 346 0 7.13 SITE 1 AC1 6 MET D 189 LYS D 192 CYS D 193 ARG D 241 SITE 2 AC1 6 ASP D 305 HOH D2017 SITE 1 AC2 5 MET B 189 CYS B 193 ARG B 241 ASP B 305 SITE 2 AC2 5 HOH B2106 SITE 1 AC3 13 ILE C 10 GLU C 12 VAL C 18 PHE C 80 SITE 2 AC3 13 GLU C 81 PHE C 82 LEU C 83 HIS C 84 SITE 3 AC3 13 ASP C 86 LYS C 89 LEU C 134 HOH C2018 SITE 4 AC3 13 HOH C2022 SITE 1 AC4 16 ILE A 10 GLY A 11 GLU A 12 VAL A 18 SITE 2 AC4 16 VAL A 64 PHE A 80 GLU A 81 PHE A 82 SITE 3 AC4 16 LEU A 83 HIS A 84 ASP A 86 LYS A 89 SITE 4 AC4 16 LEU A 134 HOH A2035 HOH A2056 HOH A2057 CRYST1 74.070 135.410 148.630 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013501 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007385 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006728 0.00000